Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Hepatol. Feb 27, 2022; 14(2): 400-410
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.400
Table 1 Baseline characteristics of patients with liver transplant versus those without liver transplant (control group)

Liver transplant
No liver transplant

n = 38740
%
n = 37679800
%
Takotsubo cardiomyopathy1100.3134300.0
Age > 651478038.2834938022.2
Age 18-652347060.62244947059.6
Age < 185001.3665954017.7
Male1623041.91667678044.3
Female2251058.12066510054.8
Caucasian3015077.82244683059.6
African American 606015.6431541011.5
Obesity8402.2501844013.3
Cardiomyopathy17704.67624202.0
Hypertension3901.034651209.2
Diabetes Mellitus7101.8548480014.6
Hyperlipidemia 12203.11075882028.6
Atherosclerosis7702.0384889010.2
Coronary artery disease7301.933958709.0
Myocardial infarction4301.115283104.1
Ischemic heart disease6201.622857706.1
Chronic kidney disease5301.420527005.4
Alcohol abuse800.210135902.7
Smoking2900.7636912016.9
Sepsis6901.821017805.6
Atrial fibrillation10302.726597607.1
Supraventricular arrhythmia2000.5755800.2
Ventricular arrhythmia5901.54150601.1